More recently, a metanalysis of 22 studies, 2959 cHL patients on the whole, showed that high density of either CD68+ or CD163+ TAM predicted shorter progression-free survival (PFS) and poorer OS, also confirming the association between large macrophage infiltrates and EBV positivity (29). The gene discussed is CD163; the disease is classic Hodgkin lymphoma.